DEVON ENERGY CORP (DVN)       68.7  +4.09 (+6.33%)

68.7  +4.09 (+6.33%)

US25179M1036 - Common Stock - After market: 68.8 +0.1 (+0.15%)


Fundamental Rating

We assign a fundamental rating of 7 out of 10 to DVN. DVN was compared to 406 industry peers in the Oil, Gas & Consumable Fuels industry. DVN scores excellent points on both the profitability and health parts. This is a solid base for a good stock. DVN is growing strongly while it is still valued neutral. This is a good combination! This makes DVN very considerable for growth investing!.




Profitability

Profitability Rating


DVN's Return On Assets of 16.48% is amongst the best returns of the industry. DVN outperforms 84% of its industry peers. The industry average Return On Assets is 3.16%.
DVN's Return On Equity of 38.59% is amongst the best of the industry. DVN does better than the industry average Return On Equity of 14.52%.

DVN has a Profit Margin of 25.69%. This is better than the industry average of 11.07%.
The Piotroski-F score of DVN is 8.00. This is a very strong score and indicates great health and profitability for DVN.
VS Industry

ROA (16.48%) VS Industry: 84% outperformed.

-76,688.64
464.78

ROE (38.59%) VS Industry: 77% outperformed.

0.03
3,513.56

Profit Margin (25.69%) VS Industry: 71% outperformed.

-234,650.00
2,367.39

Valuation

Valuation Rating


With a Forward Price/Earnings Ratio of 8.54, the valuation of DVN can be described as very reasonable.
DVN's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The Price/Earnings Ratio is 13.88, which indicates a correct valuation of DVN.
When comparing the current price to the book value of DVN, we can conclude it is valued correctly. It is trading at 4.88 times its book value.

Compared to an average industry Enterprise Value to EBITDA ratio of 7.29, DVN is valued in line with its industry peers.
DVN's Price/Earning Ratio is slightly more expensive than the industry average, which is at 11.45.
Compared to an average industry price book ratio of 1.94, DVN is valued more expensive than its industry peers. 83% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (13.88) VS Industry: 39% outperformed.

486.00
0.49

Price/Book (4.88) VS Industry: 17% outperformed.

1,736.53
0.19

Enterprise Value/ EBITDA (7.53) VS Industry: 47% outperformed.

253.42
0.08

Growth

Growth Rating


The Earnings Per Share has grown by an impressive 2052.17% over the past year.
The Earnings Per Share has been growing by 21.98% on average over the past 5 years. This is a very strong growth
Based on estimates for the next 5 years, DVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.28% on average per year.
DVN shows a strong growth in Revenue. In the last year, the Revenue has grown by 210.19%.

The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Revenue has been growing slightly by 3.45% on average over the past 5 years.
DVN is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 4.24% yearly.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS21.98% 39.74% 2052.17% 128.64% 51.14% 25.57% 11.28%
Revenue3.45% 11.12% 210.19% 40.43% 16.61% 9.73% 4.24%

Health

Health Rating


When comparing the Quick Ratio to an average industry Quick Ratio of 0.94, DVN is better placed than the average industry peer to meet its short term obligations.
An Altman-Z score of 3.71 indicates that DVN is not in any danger for bankruptcy at the moment.
When comparing the Altman-Z score to an average industry score of 1.60, DVN is in better financial health than the average industry peer.
The Piotroski-F score of DVN is 8.00. This is a very strong score and indicates great health and profitability for DVN.

DVN has a Current Ratio of 1.32. This is a normal value and indicates that DVN is financially healthy and should not expect problems in meeting its short term obligations.
DVN has a Current Ratio comparable to the industry average, which is at 1.09.
DVN has a Quick Ratio of 1.32. This is a normal value and indicates that DVN is financially healthy and should not expect problems in meeting its short term obligations.
When comparing the Debt to Equity Ratio of DVN to the average industry Debt to Equity Ratio of 0.27, DVN required more debt to finance its operations than its industry peers.
VS Industry

Debt/Equity (0.72) VS Industry: 31% outperformed.

25.82
-41.13

Quick Ratio (1.32) VS Industry: 65% outperformed.

0.00
234.27

Current Ratio (1.32) VS Industry: 60% outperformed.

0.00
234.27

Altman-Z (3.71) VS Industry: 75% outperformed.

-136,528.37
1,413.73

Dividend

Dividend Rating


DVN has a Yearly Dividend Yield of 7.57%, which is a nice return.
DVN's Dividend Yield is a higher than the industry average which is at 4.01.
DVN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.14.
The dividend of DVN is growing, but earnings are growing more, so the dividend growth is sustainable.

DVN has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of DVN has a limited annual growth rate of 3.23%.
49.57% of the earnings are spent on dividend by DVN. This is a bit on the high side, but may be sustainable.
VS Industry

Dividend Yield (7.57%) VS Industry: 80% outperformed.

0.05
76.92
DVN Daily chart

DEVON ENERGY CORP68.7

NYSE:DVN (5/13/2022, 7:08:24 PM)+4.09 (+6.33%)

After market: 68.8 +0.1 (+0.15%)

Chartmill FA Rating
GICS Sector Energy
GICS IndustryGroup Energy
GICS Industry Oil, Gas & Consumable Fuels
Earnings (Last) 05-02 2022-05-02/amc Earnings (Next) 08-01 2022-08-01
Ins Owners 0.78% Inst Owners 84.81%
Market Cap 45.34B Analysts 80.57
Valuation
PE 13.88 Fwd PE 8.54
PEG (NY) 0.11 PEG (5Y) 0.63
P/S 3.25 P/B 4.88
EV/EBITDA 7.53
Profitability
ROA 16.48% ROE 38.59%
PM 25.69 Asset Turnover 0.64
Growth
EPS 1Y 2052.17% EPS 3Y 39.74%
EPS 5Y 21.98% EPS growth Q2Q 317.78%
EPS Next Y 128.64% EPS Next 2Y 51.14%
EPS Next 3Y 25.57% EPS Next 5Y 11.28%
Revenue growth 1Y 210.19% Revenue growth 3Y 11.12%
Revenue growth 5Y 3.45% Revenue growth Q2Q 116.35%
Revenue Next Year 40.43% Revenue Next 2Y 16.61%
Revenue Next 3Y 9.73% Revenue Next 5Y 4.24%
Health
Current Ratio 1.32 Quick Ratio 1.32
Altman-Z 3.71 F-Score 8
Debt/Equity 0.72
Dividend
Dividend Yield 7.57% Dividend Growth 3.23%
DP 49.57% Ex-Date 06-10 2022-06-10 (1.27)

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA